The serum acylcarnitines profile in epileptic children treated with valproic acid and the protective roles of peroxisome proliferator-activated receptor a activation in valproic acid-induced liver injury
Valproic acid (VPA) is widely used as a major drug in the treatment of epilepsy. Despite the undisputed pharmacological importance and effectiveness of VPA, its potential hepatotoxicity is still a major concern. Being a simple fatty acid, the hepatotoxicity induced by VPA has long been considered to...
Saved in:
Main Authors: | Yiyi Ma (Author), Minglu Wang (Author), Shuaishuai Guo (Author), Tong Li (Author), Xiaodong Liu (Author), Limei Zhao (Author) |
---|---|
Format: | Book |
Published: |
Frontiers Media S.A.,
2022-11-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
The potential antiepileptic activity of astaxanthin in epileptic rats treated with valproic acid
by: Yussra Ata Yaseen Abdulqader, et al.
Published: (2021) -
Platelet counts in epileptic children receiving valproic acid
by: Lilik Indrayati, et al.
Published: (2020) -
Valproic Acid-Associated Liver Failure
by: J Gordon Millichap
Published: (2011) -
Associations between one-carbon metabolism and valproic acid-induced liver dysfunction in epileptic patients
by: Jingwei Zhu, et al.
Published: (2024) -
Valproic Acid and Thrombocytopenia
by: J Gordon Millichap
Published: (1996)